With this program, Dravet Syndrome Foundation Spain intends to address the problem of limited access to publications in the field of developmental and epileptic encephalopathies and, more specifically, Dravet syndrome, and at the same time encourage professionals to choose to publish in open access journals.
Dravet Syndrome Foundation Spain (FSD) was created with the main objective of eliminating the barriers that prevent research on Dravet syndrome from advancing, as well as encouraging the search for effective treatments that can mitigate or even cure the disease.
Along with these lines, FSD believes in the importance of accessibility to scientific information for the benefit of global knowledge flow, innovation and socio-economic development. Open access publishing allows scientists to develop their research programs based on previous results, avoiding unnecessary duplication of effort and improving quality and productivity in the research centers. In addition, open access to scientific information supports transparency, making research available to individual citizens and non-for-profit organizations. In combination, access to scientific knowledge speeds up innovations and brings treatments to market in less time.
The FSD Open-Access Support Program intends to address the problem of limited access to publications in the field of developmental and epileptic encephalopathies and, more specifically, Dravet syndrome, and at the same time encourages professionals to choose to publish in open access journals.
This Program is an ongoing call for applications and is in addition to recent research initiatives initiated by the Dravet Syndrome Foundation Spain, such as the Call for innovative research projects in advanced therapies for Dravet syndrome or the Program for the development of new scientific tools initiated last February 1st together with Tel Aviv University.
Through this Program, authors can apply for a grant to cover the open-access publishing fees required for the publication in international scientific journals of a manuscript resulting from high quality research on Dravet syndrome.
All details about the program, including eligibility and evaluation criteria, can be found HERE.